Jiro Kusunose et al.
Annals of biomedical engineering, 41(1), 89-99 (2012-08-03)
The identification of novel, synthetic targeting ligands to endothelial receptors has led to the rapid development of targeted nanoparticles for drug, gene and imaging probe delivery. Central to development and optimization are effective models for assessing particle binding in vitro.